BioCentury
ARTICLE | Politics & Policy

ASCO seeking input on 'clinically meaningful' OS

April 23, 2013 1:18 AM UTC

The American Society of Clinical Oncology is seeking comments on draft recommendations on ranges of overall survival (OS) improvements in Phase III trials that provide a "meaningful benefit" for patients with four types of cancer. According to the society, the recommendations are intended to provide a framework for the design of future clinical trials, as well as to provide investigators, patient advocacy groups and patients with "clearly defined expectations" for trials. ...